Furthermore, silencing of HDAC9 also prevented HIF-1 increase, Sp1 decrease, and consequently, the modulation of their target genes TfR1 and GPX4 in neurons in in vitro and in vivo models of stroke as demonstrated by Western blot and immunohistochemistry experiments. Here, TFRC is linked to stroke disorder.